Antibiotiques

Gramicidin S hydrochloride is a cyclic peptide antibiotic, which is a derivative of the naturally occurring antibiotic gramicidin S. It is sourced from Bacillus brevis, a type of soil bacterium. This peptide operates through a unique mode of action, whereby it disrupts bacterial cell membranes. By integrating into the lipid bilayer, it increases membrane permeability, leading to leakage of essential ions and molecules, and ultimately causing cell death.

<p>Amoxicillin is an aminopenicillin antibiotic and is used for the treatment of various bacterial infections. It works by inhibiting the synthesis of bacterial cell wall mucopeptides, leading to cell lysis and death</p>

Carumonam is a synthetic monobactam antibiotic, which is derived from chemically modifying aztreonam to enhance its antimicrobial properties. Its source is entirely synthetic, allowing for precise structural modifications to target specific bacterial pathogens. The mode of action involves the inhibition of bacterial cell wall synthesis. Carumonam binds to penicillin-binding proteins (PBPs) on the surface of bacterial cell walls, disrupting the peptidoglycan cross-linking process necessary for cell wall strength and integrity. This action results in bacterial cell lysis and death, making it effective against a range of Gram-negative bacteria.

Toxoflavin (Xanthothricin) is an antagonist of transcription factor 4 (TCF4)/β-catenin complex. Toxoflavin also acts as an inhibitor of KDM4A.

N-Acetylamphotericin B is a derivative of the well-known antifungal agent Amphotericin B, which is derived from the bacterium *Streptomyces nodosus*. This compound is an acetylated version of Amphotericin B, designed to improve certain pharmacokinetic properties. It operates by binding to ergosterol, a key component of fungal cell membranes, leading to the formation of pores that disrupt membrane integrity, causing cell death. The acetylation is intended to reduce the compound's cytotoxicity and improve its solubility in aqueous solutions, potentially allowing for enhanced therapeutic applications.

Desoxymycin is an antibiotic product that belongs to the class of aminoglycosides, which is derived from natural sources such as certain species of Streptomyces bacteria. This compound exhibits its mode of action by specifically binding to the bacterial ribosomal RNA, interfering with protein synthesis. As a result, it inhibits the replication and growth of susceptible bacterial strains.

Acetomycin, a γ-lactone from S. ramulosus, halts HCT-8 colon and L1210 leukemia cell growth.

<p>Methacycline, a tetracycline antibiotic, inhibits bacterial protein synthesis and effectively suppresses epithelial-mesenchymal transition (EMT). It blocks EMT in vitro and inhibits fibrogenesis in vivo without directly affecting the TGF-β1Smad signaling pathway. As an antimicrobial agent, Methacycline holds potential for research in pulmonary fibrosis.</p>

Mal-PEG4-VA-PBD is a drug-linker conjugate for Antibody-Drug Conjugates (ADCs), comprising the antitumor antibiotic Pyrrolobenzodiazepine (PBD), connected

Spicamycin can be used as a potent inducer of differentiation of human myeloid leukemia cells (HL-60) and murine myeloid leukemia cells (M1).

Potent, selective CHS inhibitor with 0.12 mM IC50; effective against drug-resistant fungi.

Streptonigrin: aminoquinone antibiotic; antitumor, antibacterial; blocks β-Catenin/Tcf, cytotoxic; alters hamster chromosomes; (-)-isomer, CAS#3930-19-6.

CRS-3123, a methionyl-tRNA synthetase inhibitor, is used potentially for the treatment of enteric infections.

Epiderstatin is isolated from Streptomyces pulveraceus subsp. epiderstagenes; inhibits mitogenic activity of epidermal growth factor.

Mucidin is an antifungal antibiotic that inhibits electron transfer reactions within the mitochondrial respiratory chain's cytochrome bc1 complex.

Ganaplacide hydrochloride (KAF156 HCl) is an orally administered imidazopyrimidine antimalarial agent that inhibits Plasmodium PI4K activity.

MLEB-22043 is a synthetic siderophore-monocyclic β-lactam conjugate which enters bacteria through TonB-dependent transport proteins utilizing its siderophore component, subsequently exerting antibacterial activity via its β-lactam portion. This compound acts as a broad-spectrum antibiotic, exhibiting significant inhibitory activity against pathogens such as Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa.

Saptomycin E is an antitumor antibiotic.

Antifungalagent 113 (compound 9a) serves as an effective antifungal and antibacterial agent. It exhibits strong inhibitory activity against both S. aureus and methicillin-resistant S. aureus.

Pibrozelesin, a water-soluble duocarmycin B2 derivative, binds AT-rich DNA, blocking replication and inducing cell death.

<p>2-Acetyl-2-decarboxamidotetracycline is a tetracycline-class antibiotic. It exhibits a UV absorption spectrum similar to that of tetracycline or 5-oxytetracycline at concentrations above 300 mμ, characteristic of the BCD ring system.</p>

Amicoumacin A has antibacterial activity. It also strongly suppresses inflammatory and ulcer activity.

Nikkomycin Z (Nikkomycin Z from Streptomyces tendae) is a competitive chitin synthase inhibitor.It inhibitor of the growth of filamentous fungi, insects,

Bleomycin Free Base, a glycopeptide antibiotic, halts DNA function and treats solid tumors.

Ascofuranone is an inhibitor of the ubiquinol oxidase activity of Trypanosoma brucei mitochondrial alternative oxidase (TAO), as well as an inhibitor of HsDHODH

Myxothiazol blocks mitochondrial complex III and triggers SESN2, a gene important for stress response.

Imidocarb dihydrochloride monohydrate is an effective antiprotozoal agent against the parasite B. bovis (IC50: 87 μg/ml).

Kinamycin B is an antibacterial agent with anticancer activity.

Clavicoronic acid, a β-lactamase inhibitor, boosts penicillin antibiotics against resistant bacteria.

Neocryptolepine-Cl (compound Z24) is an inhibitor of Bcthi4, demonstrating excellent antifungal activity against B. cinerea, with an EC50 value of 0.56 μg/mL.

Saroaspidin B is a dimeric form of a biphenyl triphenol, characterized as an antibiotic compound.

Amicoumacin C is a biological product derived from certain strains of the Bacillus species, specifically fermented by Bacillus subtilis. It is recognized as a potent antibiotic compound, noted for its ability to inhibit bacterial protein synthesis, primarily by interacting with the 30S ribosomal subunit, thereby hindering the translation process.

Sinefungin (Adenosyl-Ornithine) is an effective inhibitor of virion mRNA(guanine-7-)-methyltransferase, mRNA(nucleoside-2'-)-methyltransferase, and viral

Erythromycin and its derivatives; salts thereof

Erythromycylamine is a useful organic compound for research related to life sciences. The catalog number is T64443 and the CAS number is 26116-56-3.

Nortopixantrone(BBR 3438) is a novel 9-azacyclophenanthracene pyrazole that shows antitumor activity in a human prostate cancer model.

Formycin A shows antitumor and antiviral activities. Formycin A , a purine nucleoside antibiotic, is a potent human immunodeficiency virus type 1 (HIV-1) inhibitor with an EC50 of 10 μM.

A 53868A is an antibiotic, it is isolated from Streptomyces luridus.

Swainsonine (Tridolgosir) is an alkaloid isolated from Astragalus membranaceus and is a potent and reversible inhibitor of alpha-mannosidase. swainsonine has antitumour activity and induces apoptosis and cell cycle arrest in the G2/M phase.

<p>Dibekacin sulfate is an aminoglycoside antibiotic with action on bacterial protein synthesis inhibition and is used for treating severe gram-negative bacterial infections.</p>

<p>Amphotericin B is a macrocycle antibiotic with very potent antifungal effects and resistance very rarely occurs. Amphotericin B is a polyene antifungal that binds to fungal cell membrane, i.e., ergosterol disrupts the membrane permeability leading to leakage of intracellular components. It is often used as an alternative therapy for leishmaniasis and to treat severe mycoses including: systemic Candida, Cryptococcus, blastomycosis, and histoplasmosis.</p>

<p>Cefatrizine is a broad-spectrum antibiotic, which is a semisynthetic cephalosporin derived from cephalosporin C, a natural product originating from the fungus Acremonium chrysogenum. It exerts its mode of action through the inhibition of bacterial cell wall synthesis, a critical component for bacterial growth and replication. Specifically, cefatrizine targets and binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, leading to the inhibition of peptidoglycan synthesis. This disruption results in cell lysis and ultimately bacterial cell death.</p>

<p>Kanamycin B is a broad spectrum antibiotic active against both gram-positive and gram-negative bacteria, often used to treat eye infections. Compared to Kanamycin A, it exhibits stronger interaction with the acidic phospholipids.</p>

<p>Carbomycin is a macrolide antibiotic, which is derived from the bacterium Streptomyces halstedii. This antibiotic functions by binding to the 50S ribosomal subunit, thereby inhibiting bacterial protein synthesis. Through this mechanism, carbomycin effectively disrupts the growth and replication of susceptible bacterial strains, making it a potent tool in combating bacterial infections.</p>

<p>Membrane pore-forming agent; H+, K+, Pb2+ ionophore; polyether antibiotic</p>

<p>Inhibitor of protein synthesis; aminoglycoside</p>

<p>Inhibitor of RNA synthesis</p>

<p>Posizolid is an oxazolidinone antibiotic, which is a synthetic compound derived from chemical synthesis. It acts by inhibiting bacterial protein synthesis through binding to the 50S subunit of the bacterial ribosome, thereby interfering with the translation process essential for bacterial growth and reproduction.</p>

<p>Gentamicin C1a is an aminoglycoside antibiotic, which is a secondary metabolite derived from the bacterium Micromonospora. This antibiotic functions through a mode of action that involves binding to the 30S subunit of bacterial ribosomes. This binding disrupts protein synthesis by causing misreading of the mRNA, ultimately leading to inhibition of bacterial growth and cellular death.</p>

<p>Dihydrostreptomycin sesquisulfate, EP is an aminoglycoside antibiotic, structurally derived from Streptomyces griseus. This compound originates from microbial biosynthesis, a method which harnesses the natural antibiotic-producing capabilities of microbial cultures. The mode of action of dihydrostreptomycin sesquisulfate involves binding to the 30S subunit of bacterial ribosomes, which interrupts the process of protein synthesis, ultimately leading to bacterial cell death.</p>

<p>Ticarcillin disodium salt is a beta-lactam antibiotic that has in vitro activity against Gram-positive and Gram-negative bacteria. Ticarcillin is active against penicillinase-producing strains of Staphylococcus aureus, Enterobacter aerogenes, Proteus mirabilis, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Serratia marcescens, Streptococcus pyogenes, Streptococcus faecalis, and Streptococcus pneumoniae. Furthermore, it inhibits transpeptidase activity of the cell wall of bacteria which prevents peptidoglycan synthesis. It is bactericidal for many bacteria at low concentrations.</p>

<p>Kanamycin sulfate is a water-soluble antibiotic. Genes encoding kanamycin resistance are commonly used as selection markers in molecular biology .It acts during the translation mechanism in prokaryotic ribosomes to avoid bacterial cell growth.</p>

<p>Cefuroxime sodium is a sodium salt form of cefuroxime with similar action and applications as cefuroxime.</p>

<p>Amicoumacin A is an antibiotic compound, which is derived from the bacterium Bacillus subtilis. This natural source is known for its production of a variety of biologically active compounds that contribute to its utility in numerous scientific contexts. The mode of action of Amicoumacin A involves the inhibition of bacterial protein synthesis by targeting the ribosomal subunit. Specifically, it interferes with the translation process, effectively disrupting the growth and proliferation of susceptible bacterial strains.<br><br>Amicoumacin A is primarily utilized in research settings to study bacterial resistance mechanisms, as well as to explore novel antibacterial therapies. Its application in scientific research extends to examining its potential synergistic effects with other antimicrobial agents, and it serves as a model compound for understanding ribosomal inhibition. The study of Amicoumacin A not only contributes to the broader field of antibiotic development but also offers insights into the molecular interactions that underlie bacterial protein synthesis and antibiotic resistance. This compound's unique properties make it an important subject of investigation for microbiologists and pharmacologists alike, emphasizing its relevance in the ongoing battle against antibiotic-resistant pathogens.</p>

<p>Cefsulodin sodium salt is a beta lactam antibiotic in the third-generation cephalosporin family that inhibits penicillin-binding proteins (PBPs) to disrupt bacterial cell wall synthesis.</p>

<p>Tosufloxacin is a fluoroquinolone antibiotic that inhibits DNA gyrase and topoisomerase IV, which are enzymes that maintain the integrity of bacterial DNA. It binds to bacterial 16S ribosomal RNA and inhibits protein synthesis, leading to cell death by inhibiting the production of proteins vital for cell division. Tosufloxacin has been shown to be effective against a variety of bacterial infections.</p>

<p>Azithromycin N-oxide is a macrolide antibiotic derivative and is used for research purposes. Its mode of action is similar to azithromycin.</p>

<p>Potassium clavulanate is a beta-lactamase inhibitor and an antibacterial agent. The presence of potassium clavulanate in culture media inhibits the activity of beta-lactamases, which are enzymes that confer resistance to penicillin and other beta-lactam antibiotics. It also has been shown to be active against bacterial infections such as tuberculosis, sepsis, and pneumonia, where it can inhibit the growth of bacteria by interfering with their ability to form cell walls. Potassium clavulanate is also used as an antimicrobial agent for blood culture technique and antimicrobial treatment.</p>

<p>Second-generation lipoglycopeptide antibiotic</p>

<p>Ticarcillin is a beta-lactam antibiotic that inhibits the synthesis of peptidoglycan, which is an essential component of bacterial cell walls. Ticarcillin is used for the treatment of infections caused by susceptible bacteria, such as those in the respiratory tract, urinary tract, skin and soft tissues. It can also be used to treat sepsis and meningitis. Ticarcillin has a broad spectrum of activity against Gram-positive and Gram-negative bacteria, including Enterobacteriaceae (e.g., Escherichia coli) and Pseudomonas aeruginosa. Ticarcillin is not active against methicillin-resistant Staphylococcus aureus (MRSA).</p>

<p>Herbicidin B is a natural herbicidal compound, which is a secondary metabolite produced through the fermentation of certain Streptomyces species. This compound functions as a potent inhibitor of plant growth by interfering with essential physiological processes within the plant cells. The mode of action of Herbicidin B primarily involves disruption of metabolic pathways that are critical for the development and survival of plants, leading to effective control of undesired vegetation.</p>

<p>Amrubicin hydrochloride is an anthracycline chemotherapeutic agent, which is a synthetic anthracycline derivative derived from reductive amination. It functions primarily by intercalating into DNA and inhibiting topoisomerase II, an enzyme crucial to DNA replication. This mode of action disrupts DNA synthesis, leading to apoptosis in rapidly proliferating cancer cells.</p>

<p>Rifamdin is an antibiotic, which is a chemical substance derived from the source compound rifampicin. Its mode of action involves the inhibition of bacterial DNA-dependent RNA polymerase, which effectively suppresses bacterial RNA synthesis, leading to cell death. This mechanism primarily targets Mycobacterium tuberculosis, the causative agent of tuberculosis.</p>

<p>7-O-Demethyl rapamycin is a macrolide compound, which is a derivative of rapamycin, originally sourced from the bacterial species *Streptomyces hygroscopicus*. This compound operates by binding to the FK506-binding protein 12 (FKBP12), forming a complex that inhibits the mammalian target of rapamycin (mTOR) pathway. This inhibition interferes with cellular processes such as cell growth, proliferation, and survival by altering the phosphorylation state of downstream targets.</p>

<p>Erythromycin derivative</p>

<p>Erythromycin lactobionate is a macrolide antibiotic, which is derived from the bacterium *Saccharopolyspora erythraea*. Its mode of action involves binding to the 50S subunit of the bacterial ribosome, thereby inhibiting protein synthesis and leading to the suppression of bacterial growth. This mechanism effectively targets gram-positive bacteria and some gram-negative bacteria, making it a crucial agent in the fight against various bacterial infections.</p>

<p>Streptidine dihydrochloride is a biochemical compound, specifically a derivative of streptomycin, which is obtained through chemical modification of the aminoglycoside antibiotic streptomycin. It is composed of streptidine, a constituent sugar derivative, that is integral to the structure of streptomycin, rendered as a hydrochloride salt to enhance solubility and stability.</p>

<p>3'-N,N-Di(desmethyl)-3'-N-formyl azithromycin is a semisynthetic macrolide antibiotic derivative, which is synthesized through chemical modification of azithromycin. Azithromycin is originally derived from erythromycin, which is produced by the bacterium Saccharopolyspora erythraea. The modifications in this derivative result in enhanced specificity and altered pharmacokinetic properties compared to the parent compound.</p>

<p>Aminosidine is a nucleoside analogue that inhibits the HIV-1 reverse transcriptase and the integrase, which are enzymes involved in viral DNA synthesis. Aminosidine is active against Leishmania spp., but not against bacteria. Aminosidine has been shown to be effective in experimental models of human bowel disease and in patients with inflammatory bowel disease. It was also found to be active against wild-type strains of human immunodeficiency virus type 1, but not resistant mutants. The mechanism of action is the inhibition of cellular mitochondrial membrane potential.</p>

<p>DprE1-IN-8 is a potent inhibitor of DprE1, exhibiting an IC50 of less than 0.75 μM.</p>

PKUMDL-LTQ-301 is a potent inhibitor of HipA toxin. PKUMDL-LTQ-301 also inhibits E. coli persistence.